Healthtech & Wellness VC Funds

Addition is a venture capital firm founded in 2019 by Lee Fixel, previously a key investor at Tiger Global. Based in New York, Addition focuses on early and growth-stage technology companies, emphasizing sectors like e-commerce, SaaS, and fintech. Their notable investments include high-profile companies such as Allbirds, Freshworks, Chainalysis, Delhivery, dLocal, Hugging Face, Snyk, and Warby Parker. Geographically, Addition primarily targets investments in the United States, though they have a broad international scope due to their interest in global tech innovators. Their investment strategy involves a significant allocation towards both early-stage and growth-stage companies, with about one-third of their capital dedicated to early-stage ventures and the rest to more mature businesses. This allows them to support startups through various phases of their development. Addition's team is led by Fixel, who is the sole partner and decision-maker, ensuring a streamlined and decisive investment process. The firm is known for its strategic and empathetic approach, focusing on building long-term partnerships with entrepreneurs and fostering growth in their portfolio companies through active engagement and support. For startups seeking investment, Addition values clear demonstrations of potential for market leadership and significant growth. They prefer companies with a proven track record of profitability and sustainable competitive advantages. The firm's commitment to preserving legacy and company culture makes them a preferred partner for founders looking for a strategic, long-term investor.

adesso ventures is the corporate venture capital arm of adesso SE, a publicly traded IT services company headquartered in Berlin, Germany. Founded in 2022 and led by Managing Director Malte Unger, the firm invests in verticalized software, software development tooling, and digital health startups, primarily in the DACH region — Germany, Austria, and Switzerland — with selective investments across broader Europe. The firm operates as a single-LP fund backed exclusively by adesso SE, with initial investments up to 1 million euros and potential for follow-on capital at pre-seed and seed stages. The portfolio of 6 companies includes acto, an AI startup based in Paderborn; Nia Health, a digital dermatology platform; TamedAI; eCovery, a digital therapeutic for rehabilitation; Hanko GmbH, a passkey and authentication startup; Optimeleon; Flowstep; and Youth Health Tech. Investments are concentrated primarily in Germany and Estonia, reflecting the DACH-first investment mandate and adesso's core market presence. adesso ventures' strategic differentiation lies in its parent company's scale: adesso SE employs thousands of IT professionals serving enterprise clients across Germany and Europe, giving portfolio companies immediate access to a large, willing client base, top-tier software development talent, and deep technical expertise across specific industry verticals. For early-stage B2B software founders, this combination of capital with a built-in enterprise distribution network and development resources represents a compelling alternative to purely financial seed investors. The fund prioritizes opportunities where adesso Group's operational capabilities can accelerate portfolio company growth beyond what capital alone could achieve.

Adir Ventures is a New York-based investment firm founded in 2021 by Barry Karfunkel, with deep expertise in technology-enabled insurance businesses. The firm focuses on insurance carriers, distribution, and business services within the insurance industry, investing across insurance technology, financial services, digital health, health technology, and SaaS in the United States and Europe. Karfunkel and the Adir team have integrated more than 20 acquisitions, bringing direct operational experience in building and scaling insurance businesses through technology and analytics. The firm leads rounds at seed and Series A stages with checks of $1 million to $10 million. The portfolio of 7 investments includes iBynd, an insurance distribution platform; HealthyLabs, a health technology company; and Precedent, which closed a $9 million seed round. These companies reflect the firm's focus on applying software and data capabilities to insurance underwriting, distribution, and claims processes — markets where technology adoption has historically lagged behind other financial services sectors. Adir Ventures combines venture capital, private equity, and seed investing disciplines to build and grow technology-enabled insurance businesses. The firm's founding partner brings direct industry operating experience — having navigated the regulatory, actuarial, and distribution complexities of the insurance market — making Adir a more substantive strategic partner than a financial-only investor for insurtech founders. For companies building at the intersection of insurance, health technology, and enterprise SaaS, Adir's M&A track record and industry relationships provide a credible pathway to both commercial scale and strategic exit.

Adjacent is an early-stage venture capital firm led by Nico Wittenborn, a seasoned investor with prior experience at Point Nine Capital and Insight Partners. The fund stands out for its investments in high-growth, tech-driven companies such as Revolut, Chainalysis, Oura, and PhotoRoom. With a clear focus on the intersection of consumer technology and SaaS, Adjacent targets startups building platform-shifting innovations. Geographically, Adjacent leans towards U.S. and European markets, especially major hubs like New York and Paris. Their strategy is centered on relatively small, early-stage investments, often writing checks around $2-5M. Though the fund typically doesn't lead rounds, it plays a crucial role as a follow-on investor, backing companies that demonstrate early signs of scaling potential. Wittenborn's philosophy is rooted in not chasing $10B outcomes but rather in building a highly concentrated, collaborative portfolio. The fund invests across sectors like fintech, AI, and mobile applications, with recent deals including RevenueCat, Copilot, and Ostrom. Founders seeking to engage Adjacent are best suited to focus on scalability and clear market traction, as Wittenborn prefers lean operations with strong growth signals. The team operates from New York and actively reduces the number of companies they engage with to maintain close founder relationships.

Advance Venture Partners (AVP), formerly Advance Vixeid Capital Management, is a San Francisco-based evergreen venture capital firm founded in 2015 by David ibnAle, previously a Managing Director at TPG Growth. The firm is built in partnership with Advance, a family-owned multi-generational holding company that owns enduring media and technology businesses. AVP concentrates on digital health, data platforms, robotics, enterprise software, consumer technology, and B2B marketplace-based businesses across the US and Europe. AVP leads Series A, B, and C rounds with initial checks of $10 million to $25 million, and can deploy $50 million to $75 million of total capital over the life of an investment. The firm has made 74 investments to date. Notable portfolio companies include Compass, Curology, Farfetch, Rent the Runway, Vestiaire Collective, Midi Health, GrayMatter Robotics, Tegus, and Affinity. AVP writes checks into businesses with product in market, evidence of product-market fit, sound fundamentals, and large addressable end markets. The partnership team includes Alex Christ, Venture Partner Gina Sanders (also Managing Partner at Advance Publications), and Vice President Ameen Dalli. AVP takes an active ownership posture — working directly with founders on strategy, market development, and team building — reflecting the operational depth that comes from Advance's long history as a builder of media and technology companies.

ATV Capital (Advanced Technology Ventures) is an established venture capital firm specializing in early-stage investments across IT, healthcare, and energy technology sectors. With offices in Boston and Menlo Park, ATV focuses on backing high-potential companies driving innovation in these industries. The firm typically leads rounds, partnering closely with founders to provide strategic guidance and leverage its extensive network in Silicon Valley and beyond. ATV's portfolio includes a mix of disruptive startups in sectors like enterprise software, biotech, medical devices, and clean energy. It aims to identify companies that can scale rapidly while solving critical technological or medical challenges. Although primarily US-focused, ATV occasionally considers international opportunities if they align with its strategic vision and offer strong potential for growth. The firm’s investment strategy revolves around early-stage funding, typically from Series A onward, with average check sizes ranging from $5 to $15 million. ATV is known for its active involvement, often serving on boards and offering ongoing operational and strategic support. ATV’s leadership team includes seasoned investors and industry veterans who bring decades of experience in venture capital, technology, and healthcare. Founders are encouraged to approach ATV with a strong business case, significant market traction, and a clear path to scalability. With a focus on building long-term partnerships, ATV positions itself as more than just a financial backer, but as a critical player in helping startups navigate their growth journey.

Advancit Capital is a venture capital firm founded in 2011, focusing on early-stage investments in media, technology, and web3 startups. Co-founded by Shari Redstone and Jason Ostheimer, the firm leverages its deep industry relationships and strategic support to help accelerate the growth of its portfolio companies. Advancit Capital's notable investments include The Athletic, an online sports media company; Headspace, a provider of guided meditation and mindfulness training; and Thrive Global, a platform for mental well-being coaching. They also have investments in Public, a multi-asset investment platform, and Mux, a video performance monitoring platform. The firm has a portfolio of over 100 companies and has seen several successful exits, including the acquisitions of Wondery, a podcast streaming platform, and Mic, a media company targeting millennials. With a strong emphasis on forming long-term partnerships, Advancit Capital continues to support innovative startups addressing large opportunities ripe for disruption.

ADvantage VC is a venture capital firm focused on sports technology, investing in early-stage companies that are transforming the sports and entertainment industries. Founded in 2018 by Alexander Bente, great-grandson of adidas founder Adi Dassler, ADvantage builds on a legacy of sports innovation. The firm backs startups developing cutting-edge solutions in areas such as sports performance, media, fan engagement, and wearables. ADvantage has an impressive portfolio, including companies like Playermaker, a wearable tracking platform for athletes, Track160, which provides AI-driven performance analytics for soccer, and TAPPP, a service enabling interactive sports betting and content access. The firm also invests in platforms like Rooter, India's leading game streaming platform, and Flexia, which is reinventing Pilates with connected hardware. With partners based in Israel, including venture capitalist Jeremy Pressman, ADvantage is a global player. Their focus is on backing visionary entrepreneurs who are reshaping how fans and athletes experience sports.

Advantage Capital is a prominent impact investment firm founded in 1992, dedicated to providing financing to businesses and communities often overlooked by traditional capital sources. The firm has invested over $4.2 billion in more than 800 companies across various industries, including technology, renewable energy, and affordable housing. Some of their notable investments include NevadaNanotech Systems, which develops portable devices for real-time chemical analysis, and North End Teleservices, a contact center services provider in North Omaha aimed at creating local jobs and economic growth. TurboSquid, a global online marketplace for digital 3D models, is another key investment that highlights Advantage Capital's support for tech innovation and economic development in New Orleans​​. Advantage Capital emphasizes impact investing, focusing on outcomes such as job creation, community revitalization, and environmental sustainability. In 2022, the firm invested $85 million in affordable housing and raised over $635 million for solar energy projects, underscoring their commitment to driving meaningful change in underserved areas.

Advent Venture Partners is one of Europe's most established venture and growth capital investors, founded in 1981 and headquartered in London, United Kingdom. With over EUR 500 million in fund commitments under management and 151 investments over its history, the firm has backed innovative businesses across the United Kingdom, continental Europe, and the United States for more than four decades. Advent invests across two core practices: technology and growth capital, and life sciences through its dedicated Advent Life Sciences arm. The firm focuses on early and mid-stage companies across enterprise software, healthcare, drug discovery and development, diagnostics, consumer, and media, deploying initial checks of $3 million to $10 million and leading rounds. Advent's portfolio carries a strong exit track record spanning 2 IPOs and 21 acquisitions, with notable companies including Yelp, Wiz, and Farfetch. The current active portfolio comprises 28 companies. Advent's longevity reflects a consistent thesis: back founders with differentiated technology at a stage when capital and strategic guidance make the biggest difference, then support companies through successive growth phases. The firm's dual structure — one arm focused on technology and growth capital, the other on life sciences — allows it to maintain genuine sector depth in two complex, high-conviction verticals while operating with the speed and conviction of a specialist investor.

adVentures Studio is a Paris-based startup studio that focuses on building ventures targeting niche global markets. With a strong presence in Paris, New York, and San Francisco, they specialize in creating companies that address complex challenges through cutting-edge technologies, particularly in sectors like genetic engineering, AI, deep tech, and cleantech. Each startup in their portfolio is crafted with the goal of delivering not just financial success but also contributing to the common good, often with a focus on sustainable development and social impact. Their unique model blends young talents with experienced entrepreneurs and scientists, fostering innovation through a dynamic mix of expertise. adVentures uses an agile, experimental approach to developing ventures, allowing them to pivot quickly and scale efficiently. Some of their notable ventures include Wimi, a teamwork solution platform, and GEG-Tech, a pioneer in gene transfer technologies for life sciences. They also emphasize impact-driven businesses, such as BXVentures, which is dedicated to building cleantech startups for a net-zero carbon society. Led by founder Antoine Duboscq, adVentures operates with a clear mission: to breed leaders in niche markets through visionary entrepreneurship and technological innovation. They actively support ventures with agile strategies, ensuring sustainable growth and value creation across their portfolio.

Aegis Ventures is a New York-based venture studio founded in 2020 that co-founds and scales AI-native healthtech companies in partnership with leading health systems. The firm operates a distinctive Digital Consortium model, collaborating with 14 regional health systems — including Yale New Haven Health, Keck Medicine of USC, Hartford HealthCare, and Mayo Clinic affiliates — to identify clinical and operational pain points and co-found startups to address them. Co-founders John Beadle and John Driscoll serve as Managing Partners, with David Feinberg as Executive Chairman and Chris Ross, former CIO of Mayo Clinic, as Venture Partner. Aegis leads seed and Series A rounds with check sizes of $1 million to $10 million, and has co-founded and launched 5 companies that collectively raised over $68 million, with an 80% seed-to-Series A conversion rate. Portfolio companies include Ascertain (AI workflow automation), Avandra Imaging (real-world imaging data, $17.5 million Series A), Caregentic (generative AI patient companion), Hume AI (emotionally intelligent voice AI), and Optain (AI retinal imaging for disease screening). The firm concentrates its thesis across five areas: real-world data for care improvement, patient experience, workflow automation, new biomarkers for disease detection, and AI-powered clinical decision-making. The health system consortium structure gives portfolio companies direct access to clinical validation environments, institutional sales channels, and patient populations from day one — a meaningful advantage in a market where clinical credibility is the primary barrier to adoption.

Aera VC is a venture capital firm focused on investing in climate tech and frontier technologies that aim to advance humanity and create a sustainable future. Founded in 2016 by Derek Handley and Nick Winstone, Aera VC operates from New York, Singapore, and New Zealand. The firm invests globally, targeting early-stage companies that drive transformational change across various industries. Notable investments include Solugen, which transforms chemicals using plant-based processes, and Twelve, a company that recycles CO₂ into cost-competitive chemicals and fuels. Other significant investments are Shiok Meats, a Singapore-based company developing cell-based seafood, and Carbon Chain, which offers solutions to reduce greenhouse gas emissions in supply chains. Aera VC also supports startups like AstroForge, focused on space technology, and Paloma Health, an online medical practice specializing in hypothyroidism. Aera VC recently raised $42 million in the first close of its new climate-focused fund, which will be used to back up to 30 new seed investments over the next two years. The firm aims to support breakthrough technologies that can significantly reduce the world's carbon footprint and advance sustainable practices across various sectors.

Aescuvest is a prominent pan-European venture capital firm that specializes in health technology. Headquartered in Frankfurt, Germany, Aescuvest collaborates with EIT Health, giving it exclusive access to some of the most promising healthtech startups across Europe. The firm focuses on early to late-stage ventures, investing in areas such as remote monitoring, diagnostics, personalized medicine, and AI in healthcare. Notable investments include startups like Neteera and Caresyntax, showcasing their commitment to advancing healthcare technology. Aescuvest's strategy emphasizes a rigorous selection process and thorough due diligence to ensure exponential growth potential for their investments. They prefer to lead funding rounds and remain actively involved in the growth of their portfolio companies. Aescuvest targets investments primarily within Europe and Israel, fostering a network of healthcare technology-driven investors, including business angels and corporate investors. The fund's typical investment size averages around $2.85 million per round. For startups seeking investment, Aescuvest values innovation that promises substantial improvements in patient outcomes and healthcare delivery. Their approach to building an investment funnel involves leveraging partnerships and a deep understanding of the healthtech sector to identify high-impact opportunities. Key team members include experts deeply rooted in the healthcare industry, such as Helmut Nanz, whose experience and strategic insight drive Aescuvest's mission to transform healthcare through technology.

AF Ventures, formerly known as AccelFoods, is a venture capital firm based in New York that invests in high-growth consumer product companies. Established in 2014, the firm focuses on sectors such as food and beverage, health and wellness, personal and household care, beauty, and pet products. AF Ventures typically invests in companies with $10-30M+ in top-line revenue, aiming to support the creation of enduring brands. Notable investments by AF Ventures include Harmless Harvest, ByHeart, Proud Source Water, Koia, Siete Foods, and Hello Bello. The firm provides financial capital along with strategic support, leveraging a network of industry experts to help portfolio companies achieve significant growth and innovation. AF Ventures is committed to driving consumer brand innovation on retail shelves and online platforms. They manage over 35 portfolio brands and continue to identify and support companies that offer unique and disruptive products in their respective markets.

AFI Ventures is a Paris-based impact seed and pre-seed fund launched in 2020 by Ventech in partnership with Aviva France (now Abeille Assurances) and La Ruche incubator. Classified as an Article 9 fund under EU SFDR — the highest ESG designation — the firm backs entrepreneurs operating at the intersection of commercial viability and positive social or environmental impact. General Partner Audrey Soussan, also a General Partner at Ventech, leads the investment effort alongside Partner Charles Fourault, who brings 20 or more years of investment and advisory experience. AFI leads rounds, investing up to €500,000 per deal in one to two companies per month, with over 42 impact companies in its portfolio across Europe and Africa. The fund covers climate technology, circular economy, water management, renewable energy, sustainable agriculture, health tech, inclusive finance, and education. Portfolio companies include Koolboks (solar cooling), Bon Vivant (precision fermentation, $15.9 million seed), Faircraft (leather alternatives), Morfo (forest restoration), vorteX-io (flood risk management), and Oolu Solar. AFI Ventures is part of Alliance for Impact, a platform that gives founders access to a community of entrepreneurs and business angels extending well beyond the capital itself. The fund is expanding from France into Western Europe, leveraging Ventech's established networks. Its investment thesis centres on renewable energy, sustainable agriculture, and inclusive finance as categories where entrepreneurial solutions can generate measurable societal returns alongside financial ones.

Afore Capital is a San Francisco-based venture capital firm specializing in pre-seed stage investments. Founded in 2016, Afore Capital manages a $300 million fund and typically invests $500,000 to $2 million in early-stage companies that are pre-traction and pre-revenue. The firm focuses on identifying high-potential startups and helping them rapidly scale towards Series A funding rounds. Afore Capital’s diverse portfolio includes companies across sectors such as SaaS, fintech, healthcare, consumer, and enterprise technology. Notable investments include Neo Financial, a digital bank; BetterUp, a platform for professional coaching; and Curefit, a provider of digital and offline fitness services. The firm has a strong track record, with several successful exits and notable co-investments alongside top venture funds like Andreessen Horowitz and Accel​.

Agaeti Venture Capital was a Jakarta-based early-stage venture capital firm founded in 2018 by seasoned entrepreneurs and investors with deep Southeast Asia experience. In April 2020, Agaeti merged with Convergence Ventures to form AC Ventures (ACV), now one of Indonesia's leading venture platforms with $550 million or more in assets under management across five funds. The combined entity closed Fund V at $210 million in January 2024. Partners Adrian Li, Michael Soerijadji, Pandu Sjahrir (also a board member at Gojek and Indonesia chairman of Sea), and Helen Wong lead the firm from offices in Jakarta, Malaysia, and Singapore. Agaeti's original portfolio of 24 companies spanned Pre-Series A and Series A technology-enabled startups across Indonesia and Southeast Asia, with the firm leading rounds and deploying $500,000 to $10 million per investment. Focus sectors included fintech, e-commerce, health tech, MSME enablement, climate and sustainability, and consumer technology. Notable portfolio companies include PayFazz, Fore Coffee (which IPO'd on Indonesia's IDX in April 2025 at a $103 million market cap), Kargo Technologies, Waste4Change, Alami, MAKA Motors, and Koltiva. The firm has always positioned strategic value alongside capital — combining operating experience, industry knowledge, and deep local networks to help founders navigate Southeast Asia's complex, multi-market landscape. In 2025, AC Ventures expanded into growth equity while continuing its early-stage focus on emerging consumer brands, SaaS, AI, and climate technology.

AgFunder is a venture capital firm founded in 2013, with headquarters in Silicon Valley. The firm focuses on investing in transformative technologies within the food and agriculture sectors. Their investment strategy emphasizes bold and impactful innovations that address critical challenges such as climate change, population growth, and sustainability in food production. Notable investments in AgFunder's portfolio include companies like DeHaat, which is a farmers' business network for smallholder farmers, and MycoWorks, known for producing leather alternatives from mycelium. Other significant investments include Verdant Robotics, a robotics-as-a-service company specializing in agricultural spraying, and Wefarm, a peer-to-peer network for farmers in Eastern Africa. AgFunder's thematic investment approach targets high-impact areas such as indoor farming, precision agriculture, and alternative proteins. They leverage their extensive network of founders, operators, and investors to support their portfolio companies in scaling globally. The firm has raised multiple funds and invested in over 85 companies, making them one of the most active foodtech and agtech VCs worldwide. Their leadership team combines technological expertise with market knowledge, enabling them to support startups effectively from early stages through to larger growth phases. AgFunder’s mission is to drive radical transformation in the food and agriculture systems through advanced technologies​.

Agilent Ventures was the corporate venture capital arm of Agilent Technologies Inc., established on February 5, 2001 in Santa Clara, California. The unit was created to invest globally in groundbreaking, privately held early-stage technology companies, with an annual budget of up to $100 million and individual check sizes of $2 million to $10 million per company. Managing Director Maximilian Schroeck led the investment programme, which concentrated on three strategic domains: life sciences (instruments, genomics, and proteomics), wireless communications (WLAN, RF components, and mobile appliances), and optical and wireline communications (high-speed integrated circuits, packaging, and optical components). Over its lifetime, Agilent Ventures made 23 investments with 10 exits. Notable portfolio companies include Infinera (optical networking, which went public), Tropian (wireless technology), AXSUN Technologies, OEwaves, SiRiFIC Wireless, TelASIC Communications, Mission Bio, and Cellworks. The fund invested across the US and Asia-Pacific through its Acer Technology Ventures Asia Pacific partnership. Agilent Ventures provided startups access to the parent company's vast technological resources and expertise, actively partnering with portfolio companies to jointly develop new technologies and products. The unit is no longer active, reflecting the lifecycle common among corporate venture arms that operate in cycles aligned with the parent company's evolving strategic priorities. At its peak, it offered early-stage companies a rare combination of strategic validation from an established instrumentation and technology leader alongside meaningful growth capital.

Aglaia BioMedical Ventures, now operating as Aglaia Oncology Funds, is a Bilthoven, Netherlands-based venture capital firm founded in 2003 by Karl Rothweiler and Mark Krul, exclusively dedicated to investing in the fight against cancer. The team has been involved in the development of more than 100 oncology products and takes a deeply hands-on, operator-led approach to company building. Partners Folkert van Cleef and Eric van der Putten complete the investment team, alongside Venture Partner Ernst Geutjes. The European Investment Fund (EIF) is among the firm's LPs. Aglaia manages three funds — Oncology Fund I, an Oncology Seed Fund, and Oncology Fund II (which raised $65 million towards an $80 to $100 million target) — and has invested in 12 early-stage companies, six of which were co-founded by Aglaia itself. The firm leads rounds with initial check sizes of $500,000 to $10 million, typically acting as the first institutional capital provider. Notable portfolio companies include Merus (which had a successful IPO exit in May 2016), InteRNA Technologies, Sapreme Technologies, Inthera Bioscience, and Cristal Therapeutics. Aglaia's model of co-founding companies alongside its portfolio investments distinguishes it from conventional venture investors. By taking a driving role in product development from the earliest stages, the firm functions as both capital provider and operational partner — directly shaping scientific strategy, clinical prioritisation, and corporate formation in companies working to transform cancer treatment across Europe and North America.

Agronomics is a London-listed investment firm leading the charge in cellular agriculture, a field focused on producing agricultural products directly from cell cultures rather than through traditional farming. This approach holds promise in addressing critical issues like climate change, deforestation, and food insecurity. Agronomics invests in ventures aiming to disrupt animal husbandry and conventional food production, focusing on meat, dairy, leather, and other products derived through cutting-edge biotechnology, precision fermentation, and tissue engineering. Their portfolio includes over 20 companies, such as Meatable, a cultivated meat firm specializing in pork and beef, and BlueNalu, which is developing cell-based seafood products. These startups are pioneering solutions to replace conventional protein sources with more sustainable alternatives, reducing environmental impact and improving food security. Agronomics typically targets early-stage investments, leveraging its expertise to support companies through technological and regulatory challenges. The firm invests globally, with a particular focus on the rapidly growing precision fermentation and cellular agriculture sectors. Their goal is to not only provide capital but also help drive regulatory approvals and scalability for sustainable food production. Led by co-founders Jim Mellon and Denham Eke, Agronomics offers a unique blend of financial and scientific insight. Their active approach includes deep involvement in company growth strategies, particularly around impact and sustainability metrics. This positions Agronomics as a leader in shaping the future of food technology.

ah! Ventures is a dynamic investment platform that bridges the gap between promising startups and investors, with a keen focus on early-stage and Pre-Series A funding. Their angel fund, with a corpus of ₹100 crore (around $14 million), targets startups with "GLOCAL" ambitions - businesses that thrive locally with the potential for global expansion. ah! Ventures invests ₹3-5 crore per startup, providing hands-on mentorship and a robust support ecosystem for entrepreneurs. Their diverse portfolio includes over 95 investments across multiple sectors, ranging from fintech and agritech to consumer internet and deep tech. Notable startups include ventures like Medulance and Vanity Wagon, which highlight their sector-agnostic approach to investing. ah! Ventures primarily operates in India but maintains a global outlook, encouraging scalability beyond borders. With over 3,000 investors and 62,000 entrepreneurs in their network, they process more than 600 business plans monthly, selecting only the most promising ideas. Led by a team of seasoned professionals with significant experience in tech and entrepreneurship across India and Silicon Valley, ah! Ventures is focused on fostering scalable, high-growth startups. Their active involvement extends beyond capital, often leading funding rounds and providing strategic guidance to help businesses thrive.

Ahava Holdings & Ventures is a Toronto-based holding company, private equity, and early-stage venture firm founded in 2019 by Dr. Janét Aizenstros, a serial entrepreneur, author, investor, philanthropist, and member of the UN Global Compact. The firm is described as a nine-figure fund and is dedicated to BIPOC women entrepreneurs building technology companies that generate social impact — positioning it as the first impact fund in Canada led by an Afro-Canadian woman. Ahava is part of the broader Ahava Group Global ecosystem, a women-led modern media parent company operating across nine global locations. The firm operates a co-found and co-invest model, partnering at the seed and pre-seed stages with an established investment syndicate and deploying checks of $100,000 to $500,000. Investment focus spans agriculture, energy, fintech, media, real estate, technology, and wellness across Canada, the United States, and Africa. Portfolio companies include Frallain Group (African luxury brands, partnered with Condé Nast and the UN), Fetchir (SaaS dog marketplace), and ICON (on-demand community for Gen Z creators). Ahava formalises the Janét Aizenstros family legacy through a multi-generational commitment to supporting talented women entrepreneurs from marginalised communities. The firm's approach extends beyond capital to include mentorship, access to media networks, and the commercial relationships within the Ahava Group's global footprint, offering portfolio founders a differentiated support system particularly relevant to businesses building at the intersection of technology and culture.

Ahren Innovation Capital is a deep tech and science-focused investment firm, aiming to support transformational companies at the intersection of cutting-edge science and technology. With over $400 million in their latest fund, Ahren targets companies working in domains such as AI, genetics, robotics, and sustainable energy. They take an active role in nurturing early-stage to pre-IPO companies, focusing on ventures that have the potential to create new markets or disrupt existing ones. Ahren’s portfolio includes pioneering companies like Graphcore (AI hardware), Edifice Health (inflammatory disease diagnostics), and Meatable (cultivated meat). Their science partners include Nobel laureates and renowned scientists like Sir Gregory Winter and Lord Martin Rees, who bring deep expertise to the diligence process and ongoing business support. The firm has a strong network of strategic LPs, giving their portfolio access to key industry partners and customers. Led by Alice Newcombe-Ellis, Ahren's model blends visionary investment with commercial acumen, helping companies scale while maintaining a commitment to groundbreaking innovation. They prioritize building lasting relationships with founders, positioning themselves as trusted partners who contribute both capital and deep technical knowledge​.

AI Fund, founded by Andrew Ng, is a venture capital firm dedicated to investing in startups leveraging artificial intelligence to solve significant problems across various industries. The fund focuses on early-stage investments and aims to support AI-driven innovation that has the potential to transform industries and improve the quality of life. Notable investments by AI Fund include Workera, which provides personalized assessments and learning plans for upskilling in AI and data science; Landing AI, which specializes in computer vision solutions for manufacturing and industrial applications; and Cerebras Systems, known for its advanced AI compute solutions. Other significant investments include SambaNova Systems, a company focused on building advanced AI hardware and software platforms, and Osaro, which develops AI-driven robotic automation for industrial applications. AI Fund's strategy involves partnering with visionary founders to accelerate their growth and impact. They offer not only financial support but also access to a network of AI experts and industry leaders to help startups navigate challenges and scale their innovations effectively.

AI Seed is a London-based venture capital firm that focuses on early-stage investments in artificial intelligence startups. Founded in 2017, it has built a reputation as one of the UK's leading AI funds, with a portfolio exceeding 40 companies. Notable investments include Odin Vision, Rahko, and Facesoft. AI Seed supports startups primarily in sectors such as healthcare, finance, and business software, aiming to invest in innovative AI applications with the potential for significant market disruption. The fund typically invests around £100,000 in each startup, seeking 5-10% equity and often leading the seed round. It also provides extensive mentorship and support, leveraging its network to help startups access AI talent, commercial partners, and growth opportunities. AI Seed’s leadership team, including Michael Axelgaard, Jacques de Cock, and Steve Weis, brings a wealth of experience from previous successful ventures, combining technical expertise with operational know-how. While primarily active in the UK, the fund maintains connections in Silicon Valley, offering startups valuable international exposure. AI Seed’s approach emphasizes hands-on involvement, from initial funding through to scaling, with a clear strategy to prepare startups for follow-on funding and growth. The fund’s emphasis on AI-specific solutions makes it a valuable partner for founders looking to innovate within this space.

AI8 Ventures (Alpha Impact 8 Ventures) is a San Francisco-based minority-owned venture capital firm founded in 2017, operating as the strategic VC platform within 8alpha.ai. The firm describes itself as anti-venture capital — focused on solving systemic problems by investing in technology companies across three defined verticals: AI credit infrastructure, AI applications, and AI resilience technology. Managing Partners Carlos Ochoa and Nik Schrobenhauser lead the investment effort from offices in San Francisco, Seattle, Washington DC Metro, and Mexico. AI8 was named to Inc. Magazine's 2023 Founder Friendly Investors list. The firm leads seed-stage rounds with $1 million to $5 million initial checks, targeting a 3-to-5-year investment horizon across North and South America. Twenty investments to date span fintech, edtech, AI, healthtech, B2B services, telecoms, medtech, and web3. Portfolio companies include Seemexic, UnDosTres, and X0PA AI, with a notable exit — Arcus — acquired in November 2021. Co-investors include firms across the US and Latin American ecosystems. AI8 is committed to backing women and minority-led startups and promoting social mobility through technology. The firm targets founders with operating experience and math-or-science-driven approaches, seeking companies that deliver venture returns with a private equity risk profile — a positioning that reflects its belief that disciplined company selection and a focused thesis outperform broad-market scatter approaches. The fund's Americas focus spans both established US technology centres and emerging startup markets across Latin America.

African Infrastructure Investment Managers (AIIM) is a prominent private equity firm that focuses on investing in critical infrastructure projects across Sub-Saharan and North Africa. Established in 2000, AIIM is a wholly-owned subsidiary of Old Mutual Alternative Investments, one of Africa’s leading investment groups. The firm’s headquarters is in Cape Town, South Africa, with additional offices in Nigeria, Kenya, and Côte d'Ivoire, allowing it to have a deep understanding of the diverse African business environment. AIIM manages assets valued at approximately USD 2.8 billion and has a robust portfolio of over 74 infrastructure projects spanning various sectors, including energy, transport, telecommunications, and water. The firm’s investment philosophy is centered on long-term value creation, targeting projects that not only offer substantial financial returns but also contribute to the economic development and sustainability of the regions they serve. AIIM's track record includes managing several highly successful funds, such as the African Infrastructure Investment Fund (AIIF) series, which has been instrumental in financing large-scale infrastructure projects across the continent. These funds focus on sectors that are critical to Africa's growth, including renewable energy, where AIIM has made significant investments to help transition the continent to more sustainable energy sources. With a team of 44 investment professionals, AIIM brings extensive experience and sector-specific knowledge, ensuring that their investments are managed with the highest level of expertise. AIIM continues to play a vital role in driving Africa’s infrastructure development, helping to unlock economic potential and improve the quality of life for millions across the continent.

Audacious Ventures is a venture capital firm dedicated to supporting the world's most ambitious founders from the earliest stages of their entrepreneurial journeys. Founded in 2020, the firm has quickly made a name for itself with its unique approach that blends traditional seed-stage investing with a strong emphasis on talent acquisition for its portfolio companies. In April 2024, Audacious announced its $150 million second fund, Audacious 2.0, which continues its mission to invest in sectors such as AI, fintech, healthcare, construction tech, and climate tech. What sets Audacious apart is its deep focus on helping founders build A+ teams, particularly in critical areas like engineering, sales, and marketing. Half of Audacious' team comprises experienced recruiters who actively run searches for portfolio companies, ensuring they attract top-tier talent as they scale. This hands-on support reflects the firm’s belief that startup success hinges on exceptional teams and large market opportunities. Audacious Ventures has invested in several high-growth companies, including Vartana, Multiverse, Suppli, and Ignition. These investments underscore the firm’s commitment to backing startups that have the potential to become industry leaders. Unlike many venture firms, Audacious does not take board seats, preferring instead to focus on providing value through strategic hiring support and then stepping back to let founders lead their companies to success​.

AIP Seed is a Warsaw, Poland-based venture capital fund founded in 2009 by Dariusz Żuk, one of the first seed funds in Europe. Żuk previously founded the Academic Entrepreneurship Incubators (AIP) in 2004, a programme that has supported more than 20,000 startups across Poland. AIP Seed invests in early-stage technology companies, prioritising ambitious founders from Poland and the Polish diaspora who are building technologies with global potential. In 2022, AIP Seed 2.0 was established with €25 million in capitalisation, aiming to invest in 100 additional startups from the Central and Eastern Europe region by 2025. The firm typically invests up to $250,000 at pre-seed and seed stages, having backed more than 120 startups to date. Portfolio companies include CallPage, Plenti, Foodsi (which raised over €2.5 million in total), GLOV, SiDLY, and Qpony-Blix. Foodsi completed a €1.2 million seed extension in October 2024. The firm leads rounds and combines capital with strategic expertise through Competence Hubs offering support in AI technology, marketing, and finance. AIP Seed places AI and large language model technologies at the centre of its investment thesis, seeking companies where AI is integral to the core solution rather than peripheral. The fund actively supports female founders and impact-driven ventures contributing positively to society and the environment. Żuk's deep roots in Poland's entrepreneurial infrastructure, combined with a pan-CEE geographic lens, position AIP Seed as a foundational early partner for founders looking to build globally competitive companies from Central Europe.

Air Liquide, a global leader in gases, technologies, and services for industry and healthcare, is deeply committed to advancing sustainability and innovation through its strategic plan, ADVANCE. This strategy, designed for 2025, integrates financial performance with sustainable development goals, focusing heavily on decarbonization and the growth of key future markets, such as hydrogen and electronics. The company plans to reduce its CO₂ emissions by one-third by 2035 and aims for carbon neutrality by 2050. To achieve these goals, Air Liquide is investing significantly, with approximately 50% of its industrial investments allocated to the energy transition, including hydrogen technologies. The company is also simplifying its organizational structure to enhance agility and performance, enabling quicker decision-making and better customer service. Air Liquide’s efforts in decarbonization are demonstrated by projects like the large-scale Cryocap™ CO₂ capture unit in Rotterdam and the development of a global hydrogen distribution network through partnerships like TEAL Mobility with TotalEnergies. With over 66,000 employees across 60 countries, Air Liquide continues to drive forward with its dual focus on growth and sustainability, positioning itself as a leader in the transition to a low-carbon economy​.

Air Street Capital is a leading venture capital firm focused on AI-first companies, headquartered in London. Founded by Nathan Benaich, the fund aims to back innovative startups leveraging artificial intelligence across various sectors, including life sciences, enterprise software, and consumer technology. The firm has made significant investments in notable companies such as Exscientia, a pharmaceutical company listed on NASDAQ; Graphcore, an AI semiconductors company acquired by SoftBank; and Intenseye, a workplace safety platform utilizing computer vision. Other prominent investments include Recursion, ZOE, and Stability AI. Air Street Capital's investment strategy involves early-stage funding, actively iterating on product and market strategies from day one. The fund's typical investment size ranges from seed to Series A rounds, ensuring substantial support for startups at their most critical stages of development. The firm emphasizes creating enduring companies with lasting market impact, guided by a rigorous, science-driven approach to investment. The team at Air Street Capital includes experts like Alex Chalmers and Paula Pastor, who bring extensive experience in legal, operations, and platform development. Their collective expertise and strategic insights help portfolio companies navigate complex challenges and scale effectively. With a robust portfolio and a clear focus on AI-driven innovation, Air Street Capital stands out as a pivotal player in the venture capital landscape, driving forward the capabilities and applications of artificial intelligence across industries​.

Airbus Ventures, established in 2016 and headquartered in Menlo Park, California, is the venture capital arm of Airbus Group. The firm focuses on early to growth-stage investments in innovative startups that aim to address significant global challenges through advanced technologies. Their investment sectors include autonomous mobility, electrification, low-carbon economy, advanced materials, manufacturing systems, next-generation computing, sensing, and security. The portfolio of Airbus Ventures includes a wide range of companies that leverage cutting-edge technology. Notable investments include IonQ, a developer of quantum computing solutions; Astra, a provider of space mission launch solutions; and Humatics, which develops control systems for collaborative robots. Other significant investments are in companies like AEye, specializing in AI and cloud-enabled LiDAR sensors, and Tekion, an AI-driven dealership management system for auto dealers. Airbus Ventures has successfully nurtured numerous startups, with several achieving significant milestones such as public listings or acquisitions. For example, IonQ went public and is a leading player in the quantum computing space, while Astrocast and ispace are other prominent companies in their portfolio that have made substantial progress in their respective fields. The firm is managed by a team of experienced professionals, including Thomas d'Halluin, Claas Kohl, Lewis Pinault, and Mathieu Costes, who bring extensive expertise in venture capital and technology innovation.

AirTree Ventures, established in 2014 and headquartered in Sydney, Australia, is a prominent venture capital firm focusing on early-stage investments. They have a strong portfolio of over 178 companies, primarily investing in technology startups across Australia and New Zealand. AirTree is known for backing innovative and high-growth companies in sectors such as financial software, enterprise applications, and high-tech solutions. Notable investments include unicorns like Employment Hero, a cloud-based HR management solution; Linktree, a tool for creators and businesses; and Immutable, a blockchain infrastructure provider for NFT games and applications. AirTree has also seen successful exits from companies like Prospa and Lumos Diagnostics, which have gone public, as well as acquisitions such as MILKRUN by Woolworths Group. AirTree's investment strategy involves leading seed to Series B rounds with an average check size typically ranging from $1M to $10M. They are known for their supportive approach, offering not just capital but also strategic guidance and resources to help startups scale.

AiSprouts is a Silicon Valley-based venture capital firm, specializing in AI-driven startups that aim to enhance human potential. Founded in 2019 by Suman Talukdar, the firm operates out of Menlo Park, California, and is investing from its second fund. AiSprouts targets early-stage companies, primarily focusing on sectors such as AI, robotics, and business software. Notable investments in their portfolio include HaydenAI, BoostupAI, and Zero Systems, with successful exits like Apprente (acquired by McDonald’s) and 6D.ai (acquired by Niantic). They typically invest in 8-10 companies per year, aiming for a total of 30 investments over three years. Recent activity includes the $90M Series C raise by HaydenAI and an $11M Series A for Activeloop. AiSprouts offers deep operational support, leveraging Talukdar’s experience with five back-to-back exits and a network of prominent Silicon Valley technologists and investors. Their investment strategy emphasizes AI applications across various industries, aiming for sustainable growth and technological impact.

AIX Ventures is a specialized venture capital firm dedicated to investing in early-stage AI startups. Founded by renowned AI practitioners such as Richard Socher, Chris Manning, and Pieter Abbeel, AIX Ventures is deeply embedded in the AI community. The firm’s focus is on partnering with companies where AI is a core component of the product, spanning sectors like natural language processing, robotics, healthcare, and more. AIX Ventures manages its investments through funds, including its recent $202 million Fund II, which underscores its commitment to driving the future of work through AI. The firm typically invests between $1 million and $5 million at the Pre-Seed to Series A stages and is known for leading funding rounds while collaborating with other top investors and angels. The firm's portfolio includes groundbreaking AI companies such as Hugging Face, Weights & Biases, You.com, and Perplexity. These companies are at the forefront of AI innovation, pushing the boundaries of what is possible in their respective fields. AIX Ventures is not just an investor but also a partner in company-building, offering strategic guidance, technical expertise, and a strong network to help founders navigate the complex challenges of scaling AI technologies. The firm’s goal is to be deeply involved with its portfolio companies from the early stages through to their long-term success.

AJU IB Investment, founded in 1974, is a prominent South Korean venture capital and private equity firm, headquartered in Seoul’s Gangnam district. Known as one of the oldest VC firms in the country, AJU IB focuses on multi-stage investments spanning from early-stage startups to late-stage ventures and even buyouts. Their portfolio emphasizes industries like healthcare, life sciences, technology, and renewable energy. Key investments include companies such as Seer, Kymera Therapeutics, and Arcellx, showcasing their commitment to innovative, high-impact sectors. With over 270 investments under their belt, AJU IB Investment maintains a robust presence both in South Korea and the United States, aiming to scale businesses globally. They invest in diverse sectors, with recent activity concentrated on enterprise AI, healthcare tech, and digital therapeutics. Their approach often involves leading funding rounds while offering strategic guidance throughout the growth phases of their portfolio companies. AJU IB's seasoned leadership team, including CEO Ji-Won Kim and Managing Director Changsoo Yoon, ensures that they remain at the forefront of venture capital in Asia. Startups seeking to partner with AJU IB should prepare for a rigorous selection process, as the firm emphasizes scalability, strong business fundamentals, and innovative approaches within its chosen sectors. This focus has enabled them to secure exits in notable companies like Apellis Pharmaceuticals and Molecular Templates. AJU IB Investment continues to expand its global reach and impact.

Alabaster Co. is a publishing company founded in 2016 that blends creativity, beauty, and faith to create visually stunning editions of the Bible and other religious texts. The company was started by Brian Chung and Bryan Ye-Chung, who shared a vision of making the Bible more accessible and engaging, particularly in a world increasingly influenced by visual culture. Their beautifully designed Bibles integrate visual imagery with thoughtful design, transforming traditional biblical texts into artful experiences that resonate with modern readers. Alabaster's mission is to present the story of God as not only spiritually enriching but also aesthetically beautiful. This approach reflects their belief that beauty plays a crucial role in deepening one's connection with faith. The company's products are intended to invite readers into a deeper, more contemplative engagement with the Scriptures, helping them see the Bible in a new light. In addition to Bibles, Alabaster Co. has expanded its offerings to include devotionals, Bible studies, and other home goods, all designed with the same commitment to beauty and quality. Their work has sparked conversations about faith and beauty, making their products popular not just for personal use but also as conversation pieces in homes.

Alarabi Investments is a Dubai-based investment management firm founded in 2018, incorporated in the Dubai International Financial Centre (DIFC) and regulated by the Dubai Financial Services Authority (DFSA). With offices in Dubai, Riyadh, and Mumbai, the firm specialises in alternative investments and active portfolio management across venture capital, private equity, and hedge fund asset classes. Alarabi focuses on supporting ambitious MENA-based startups delivering change, value, and societal impact across the Gulf region and beyond. The firm targets early and growth stage companies in technology, healthcare, renewable energy, fintech, AI, blockchain, and data science, deploying $100,000 to $500,000 per deal at seed and Series A stages with a total ticket of $1 million to $5 million per investment over a 3-to-5-year horizon. Portfolio companies include Nala Health (clinics and outpatient services) and Coded Minds (educational software). Geographic coverage spans the UAE, Saudi Arabia, Bahrain, Jordan, Lebanon, Egypt, Oman, Kuwait, and Qatar, with selective investment activity in Africa and North America. Alarabi's investment philosophy centres on fostering entrepreneurship as a driver of economic growth and social progress across the MENA region. The firm takes a stage-agnostic approach within its core geographies, backing founders at the point where strategic guidance and capital can most meaningfully influence company direction. Its DIFC regulation and multi-city presence across the Gulf and South Asia provides portfolio companies with credibility and access across some of the world's fastest-growing emerging markets.

Alberts Impact Ventures is a Sydney-based impact-focused venture capital firm backed by the Albert family, a fifth-generation Australian dynasty founded in 1885 and renowned for supporting artists including AC/DC and the Easybeats. The family launched Alberts Impact Capital in 2021 with its inaugural AUD 16 million (approximately US$11.4 million) early-stage impact fund. CEO David Albert leads the firm alongside siblings Ingrid, Emily, and Kirsty Albert as executive directors, with Investment Manager Lisa Fedorenko and Head of Strategy Glenn Bartlett managing day-to-day operations. Andrew Rothery chairs the investment committee. The fund invests across four impact themes — equality, vibrant culture, healthy minds, and sustainable environment — targeting pre-seed, seed, and Series A companies with check sizes of $100,000 to $500,000. With 13 portfolio investments to date across Australia and New Zealand, the firm backs business models with social impact embedded at their core. Portfolio companies include ULUU (biomaterials), MGA Thermal (energy storage), Amber (energy), Tixel (ticketing), Muso (music analytics), Like Family (social care), Sendle (carbon-neutral delivery), AirRobe (circular fashion), and Harvest B (food products). Alberts Impact Ventures holds an ImpactAssets 50 designation, reflecting its standing among recognised impact fund managers globally. The firm's distinctive heritage in arts and culture gives it credibility in creative and lifestyle sectors that few impact investors can match, while its environmental and social themes reflect a coherent long-term view of where durable value creation and genuine impact intersect.

AlbionVC, founded in 1996 and based in London, is a leading venture capital firm that focuses on early-stage investments in B2B software, healthcare, and deep tech companies primarily in the UK. The firm manages around £1 billion in venture funds and supports companies from seed to Series B stages. Notable investments in AlbionVC's portfolio include Quantexa, a data and analytics company specializing in contextual decision intelligence; Oviva, which provides app-guided programs for changing dietary and lifestyle habits; and Phrasee, a brand language optimization solution. The firm has also seen successful exits, such as Orchard Therapeutics, which focuses on gene therapies for life-threatening diseases, and Egress Software, a provider of data security solutions. AlbionVC is known for its hands-on approach, providing long-term capital and expertise to help visionary founders scale their businesses. The firm's investment strategy is characterized by its deep sector knowledge and a strong focus on innovation and growth.

Album VC is a Lehi, Utah-based venture capital firm founded in 2014 by Sid Krommenhoek, John Mayfield, and Diogo Myrrha. With $890 million in assets under management across four funds — including Fund IV at $200 million, 10 times the size of its debut fund — Album has made nearly 190 investments in early-stage technology startups. The firm focuses on pre-product-market-fit companies at pre-seed, seed, and Series A stages, deploying initial checks of $1 million to $1.5 million into software, AI, cybersecurity, fintech, healthtech, SaaS, and edtech companies across the United States. Album has an exceptional track record in the Utah technology ecosystem, having backed 7 of the state's tech unicorns — a clean 7-for-7 record. The portfolio has produced 2 IPOs and 15 acquisitions. Notable holdings include Podium (customer interaction platform), Divvy (expense management, acquired by Bill.com), MX (open finance), Owlet (baby health), Filevine (legal tech), Neighbor (storage marketplace), Andela (developer talent), and TaxBit (crypto tax). The founding team are experienced entrepreneurs who bring direct operating perspective to their work with founders, focusing on strategy, hiring, and fundraising. Album's investor relationships reflect a founder-friendly culture built on genuine human connections and long-term partnership thinking rather than transactional dynamics. The fund's growth from its first vehicle to a $200 million fourth fund reflects consistent LP confidence in the team's ability to identify and support the next generation of category-defining technology companies.

BioCity is a leading life sciences incubator and early-stage investor, renowned for its focus on nurturing innovative ventures within the UK’s vibrant biotech ecosystem. With hubs across Nottingham, Alderley Park, and Scotland, BioCity supports a wide array of startups, especially those pioneering breakthroughs in biotechnology, medical devices, and drug discovery. The fund typically invests between £50,000 to £250,000, targeting companies at the seed stage, often co-investing alongside industry giants like AstraZeneca and prominent angel investors. Notable investments include Maxwellia, a pioneer in converting prescription drugs to over-the-counter solutions, and NanoSyrinx, which is developing precision therapeutics. BioCity's strategic approach is sector-agnostic within life sciences, providing not just capital but also high-end laboratory space, business support, and access to a network of industry experts. The team is led by seasoned professionals, including Dr. Imelda Juniarsih, known for her keen eye in identifying high-potential early-stage ventures. While their primary geographic focus is the UK, they are open to opportunities that align with their mission of advancing life sciences innovation. Startups seeking investment are encouraged to engage early, as BioCity values deep, collaborative relationships with its portfolio companies, often built through long-term incubation and mentorship.

Aleph VC, founded in 2013 and based in Tel Aviv, is a prominent venture capital firm focused on early-stage investments in Israeli entrepreneurs. With $850 million under management, Aleph specializes in sectors such as fintech, digital health, cybersecurity, AI, and machine learning. The firm aims to build impactful global brands by providing strategic guidance and access to global markets. Notable investments in Aleph's portfolio include Lemonade, a global insurance company powered by AI and behavioral economics; Melio, which offers digital payment tools for small businesses; and Nexar, a dashcam and edge-AI platform for improved driving. Aleph has also backed companies like Freightos, a digital freight marketplace, and Placer.ai, a leader in location analytics. Aleph's investment strategy typically involves seed and early-stage funding, with investment sizes ranging from $2 million to $12 million. The firm has a strong track record of successful exits, including the public offerings of companies like Lemonade and Monday.com, and acquisitions such as Raftt by Wiz. The team at Aleph is led by co-founders Michael Eisenberg and Eden Shochat, along with partners Yael Elad and Tomer Diari. They leverage their extensive network and expertise to help portfolio companies grow and succeed on a global scale. Aleph's focus on innovation and strong support for its portfolio companies has established it as a leading venture capital firm in Israel​.

Alexandria Real Estate Equities, Inc. (NYSE: ARE) is a prominent real estate investment trust (REIT) specializing in collaborative life science campuses. Founded in 1994, Alexandria is a pioneering force in the life science real estate niche, owning, operating, and developing innovative campuses in major urban locations known for their scientific and technological advancements. The company's extensive portfolio spans key innovation clusters across North America, including Greater Boston, San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City. As of March 31, 2024, Alexandria's total market capitalization is $34.4 billion, with an asset base of 74.1 million square feet, which includes operating properties, properties under construction, and planned development projects. Alexandria's success is built on its proven cluster model, which integrates essential components such as strategic location, cutting-edge innovation, top-tier talent, and substantial capital. This model has allowed the company to create and nurture thriving life science ecosystems that facilitate groundbreaking research and development in fields such as biotechnology, pharmaceuticals, and agtech. In addition to real estate, Alexandria operates several strategic verticals, including Alexandria Venture Investments, which invests in disruptive life science companies, and a strong focus on corporate responsibility, promoting sustainability and social impact initiatives. The company's mission-driven approach and operational excellence make it a trusted partner for nearly 800 tenants, driving stable and resilient cash flows through high-quality, long-term leases with diverse tenants.

Alfvén & Didrikson is a Stockholm-based venture capital firm founded in 2010 by Hjalmar Didrikson and Måns Alfvén. The firm focuses on investing in fast-growing companies in Northern Europe, particularly in sectors like fintech, SaaS, software, healthcare, media, and entertainment. Their investment stages range from pre-seed to Series A. Notable investments by Alfvén & Didrikson include Trustly, Quinyx, Acast, Mentimeter, Sympa, and Airmee. These companies span various industries, from online payments and workforce management to podcast platforms and logistics​. The firm prides itself on being a long-term backer of passionate entrepreneurs and teams with international growth ambitions. They emphasize active ownership and aim to support companies in scaling and achieving significant market impact​.

Algebra Ventures, Egypt's leading tech-focused venture capital firm, excels in nurturing transformative startups in the MENA region. With a robust portfolio that includes notable names like Halan, Brimore, and Eventtus, Algebra Ventures focuses on high-impact sectors such as fintech, agtech, edtech, logistics, and healthcare. They invest primarily in Egypt but also target broader African markets, leveraging their $100 million second fund to expand their reach. The firm’s investment strategy centers on multi-stage funding, from pre-seed to Series B, with check sizes ranging from $0.5 million to $5 million. They are active lead investors, often the first institutional backers for their portfolio companies. Algebra Ventures is not just about funding; they provide comprehensive support in strategy, operations, and talent development, ensuring startups can scale effectively. Key team members include co-founders Tarek Assaad, who brings Silicon Valley experience, Karim Hussein, and Ziad Mokhtar, along with general partners Laila Hassan and Omar Khashaba. They operate out of Cairo, where they have fostered one of the region's most dynamic entrepreneurial ecosystems. Algebra Ventures is approachable through direct engagement at industry events and via their network of co-investors. Startups seeking investment should demonstrate strong fundamentals and a clear path to solving real-world problems, especially those unique to emerging markets in Africa and the Middle East.

Align Ventures is a venture capital firm that focuses on early-stage investments in startups that are reshaping industries through technological innovation. The firm emphasizes companies operating in sectors like health tech, retail, and B2B SaaS. Their strategy is centered on partnering with mission-driven entrepreneurs who align with their goal of building sustainable businesses with long-term growth potential. Align Ventures is highly selective in its investments, preferring to concentrate on a few high-potential startups that exhibit strong market demand and scalability. Their portfolio includes companies across various stages of growth, reflecting their balanced investment approach that aims to mitigate risks while maximizing returns. The firm takes an active role in guiding their portfolio companies through different growth stages. This includes providing operational support, strategic guidance, and leveraging their network to facilitate partnerships and market access. Align Ventures maintains a hands-on relationship with founders, ensuring that their ventures are well-positioned to achieve milestones that drive value creation. Align also stands out for its commitment to long-term partnerships. They emphasize a strong cultural and strategic fit between the VC firm and the startups they back, ensuring alignment in vision and objectives. Through regular performance reviews and data-driven insights, the firm helps its portfolio companies navigate challenges and capitalize on opportunities, making Align Ventures a strategic partner beyond just capital investment.

Aligo VC is a Poland-based venture capital firm with a strong focus on early-stage investments in healthtech, cleantech, and energy tech sectors. The firm actively seeks out innovative startups addressing global challenges, particularly those with technologies that improve human health or reduce environmental impact. Aligo VC typically invests in Polish companies, but it also supports businesses aiming for international expansion. The firm's ticket sizes range from €200,000 to €500,000, and they often engage as the first investor in pre-revenue startups, demonstrating a willingness to take on early-stage risks. Aligo's diverse portfolio includes digital therapeutics, diagnostic platforms, energy storage solutions, and SaaS models focused on carbon footprint management. Notable investments include companies like Smarter Diagnostics, Envirly, and Carein, which reflect their dedication to advancing both healthcare and environmental technology. The firm is led by a seasoned team of professionals, including Agnieszka Stochmal and Łukasz Mańkowski, who bring decades of VC experience and a hands-on approach to scaling startups. With a mission to support projects that create meaningful impact, Aligo VC positions itself as a key player in fostering innovation in Poland and beyond.